Quaker Wealth Management’s Revelation Biosciences Warrant REVBW Stock Holding History

Quaker Wealth Management’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3	Hold	387	–	–	﹤0.01%	972
2025 Q4	$4	Hold	387	–	–	﹤0.01%	965
2025 Q3	$5	Hold	387	–	–	﹤0.01%	839
2025 Q2	$5	Buy	+387	New	+$5	﹤0.01%	866

Other funds holding REVBW

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.18B AUM 26.57% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SIA

Soltis Investment Advisors St. George, Utah $1.59B AUM 23.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Quaker Wealth Management's REVBW Position: Q1 2026 in Review

Quaker Wealth Management held its Revelation Biosciences Warrant (REVBW) position steady in Q1 2026 at 387 shares worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #972.

Quaker Wealth Management first reported a position in REVBW in Q2 2025 and has held it in 4 quarters since. The position peaked at $5 in Q3 2025. 11 funds tracked by Wall St. Rank hold REVBW as of Q1 2026.

Quaker Wealth Management held 387 shares of Revelation Biosciences Warrant worth $3 as of Q1 2026.
Quaker Wealth Management left its Revelation Biosciences Warrant share count unchanged in Q1 2026.
Revelation Biosciences Warrant made up ﹤0.01% of Quaker Wealth Management's portfolio in Q1 2026, its #972 holding.
Quaker Wealth Management first reported a position in Revelation Biosciences Warrant in Q2 2025 and has held it in 4 quarters since.
Quaker Wealth Management's Revelation Biosciences Warrant position peaked at $5 in Q3 2025.
11 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q1 2026.

Based on Quaker Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.